[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$ltrn](/topic/$ltrn)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$JURIS #LUNC $KNEEL $PACO $LTRN $BENANCE $SMF $USTC"  
[X Link](https://x.com/IkdRoberto/status/1979166922039075301) [@IkdRoberto](/creator/x/IkdRoberto) 2025-10-17T12:45Z 1589 followers, 1372 engagements


"$wLUNA #KNEEL #LUNC #LUNA #crypto not a #memecoin 💫 #GrokImagine #Halloween2025 ♦♦♦👐 😵💫"  
[X Link](https://x.com/DRic2hard/status/1978972375854076335) [@DRic2hard](/creator/x/DRic2hard) 2025-10-16T23:52Z 1164 followers, XXX engagements


"#LUNCcommunity I have a special message for all $LUNC & $JURIS & $KNEEL & $LTRN haterss. 👇😘"  
[X Link](https://x.com/LUNCtron/status/1978961445506228530) [@LUNCtron](/creator/x/LUNCtron) 2025-10-16T23:09Z XXX followers, 1847 engagements


"🎥 Lantern Pharma $LTRN: Precision Oncology Powered by AI In our recent interview CEO Panna Sharma detailed how @LanternPharma is leveraging its RADR AI platform to accelerate cancer drug development and cut early-stage costs by up to 80%. Key Takeaways for Investors: Global Oncology AI Platform: RADR integrates 200B+ datapoints to guide precision drug development reduce costs and improve trial success rates. Clinical Pipeline: Three assets in trials - LP-300 (Phase X $4B non-small cell lung cancer never-smoker market) LP-184 (DDR-deficient tumors $10B+ potential) LP-284 (aggressive B-cell"  
[X Link](https://x.com/RedChip/status/1978839620310769673) [@RedChip](/creator/x/RedChip) 2025-10-16T15:05Z 5896 followers, 32.5K engagements